GO:0120015 sterol transfer activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0120015 sterol transfer activity describes a molecular function that removes a sterol from a membrane or monolayer lipid particle, shields it in a hydrophobic pocket, and delivers it to an acceptor membrane or lipid particle.
• Sterol transfer proteins such as STARD4, STARD5, NPC1, NPC2, and ORP family members mediate non-vesicular sterol movement between organelles.
• Defects in sterol transfer cause cholesterol accumulation in Niemann-Pick type C disease and disrupt mTORC1 signalling at ER-lysosome contacts.
• Macrophage-derived 25-hydroxycholesterol, generated during inflammatory sterol transfer, promotes vascular inflammation and atherogenesis.
• Sterol transfer activity is essential for steroidogenesis, bile acid synthesis, and maintenance of membrane sterol gradients.
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal dissection of sterol transfer genes in disease and metabolism.
Description
Sterol transfer activity (GO:0120015) is a molecular function that moves sterols between membranes or lipid particles without using vesicular traffic. The reacting protein removes a sterol molecule from a donor membrane or monolayer lipid particle, transports it through the aqueous phase while it is protected inside a hydrophobic pocket, and then delivers it to an acceptor membrane or lipid particle. This activity is distinct from simple diffusion because it requires a protein catalyst and a shielded hydrophobic binding cavity. Sterol transfer proteins are central to intracellular cholesterol distribution, membrane lipid homeostasis, and lipid droplet dynamics. Researchers study this term because defects in sterol transfer underlie lysosomal storage disorders, atherosclerosis, and metabolic disease. The QuickGO definition emphasizes three steps: removal, protected transport, and delivery, which together distinguish true sterol transfer from sterol sensing or sterol synthesis.
sterol transfer activity At A Glance
| GO ID | GO:0120015 |
|---|---|
| GO term | sterol transfer activity |
| Ontology | molecular_function |
| Synonym | intermembrane sterol transfer activity; sterol carrier activity |
| Definition | Removes a sterol from a membrane or a monolayer lipid particle, transports it through the aqueous phase while protected in a hydrophobic pocket, and brings it to an acceptor membrane or lipid particle. |
| Major function | Non-vesicular movement of sterols between membranes and lipid particles |
| Representative proteins | STARD4, STARD5, NPC1, NPC2, OSBP, ORP family members |
| Cellular context | ER, lysosome, plasma membrane, mitochondria, lipid droplets |
| Disease relevance | Niemann-Pick type C, atherosclerosis, steroidogenic defects, metabolic disease |
What Is GO:0120015?
In our own words, GO:0120015 sterol transfer activity is the protein-mediated process of extracting a sterol from a donor membrane or monolayer lipid particle, carrying it through an aqueous environment inside a hydrophobic pocket, and inserting it into an acceptor membrane or lipid particle. It is also known as intermembrane sterol transfer activity or sterol carrier activity.
Why Is sterol transfer activity Important in Cell Biology?
Sterol transfer activity is important because cholesterol and other sterols must be distributed precisely among organelles to support membrane integrity, signal transduction, and lipid metabolism. When sterol transfer fails, sterols accumulate in the wrong compartment, as seen in Niemann-Pick type C disease where lysosomal cholesterol trapping disrupts mTORC1 signalling and drives aberrant growth. In macrophages, sterol transfer and oxysterol production promote vascular inflammation and atherosclerosis. Sterol transfer also supplies substrate for steroid hormone synthesis and bile acid production, making it essential for endocrine and hepatic function. Because this activity is a molecular function, it can be studied with purified proteins, reconstituted liposomes, and CRISPR-engineered cell models.
• Maintains cholesterol gradients between the plasma membrane, ER, lysosomes, and mitochondria.
• Enables non-vesicular sterol delivery required for steroidogenesis and bile acid synthesis.
• Supports lipid droplet formation and turnover by moving sterols into and out of monolayer particles.
• Is dysregulated in Niemann-Pick type C disease, causing lysosomal cholesterol accumulation and mTORC1 activation.
• Contributes to atherosclerosis through macrophage oxysterol production and vascular inflammation.
• Provides a druggable node for metabolic and cardiovascular disease research.
• Can be reconstituted in vitro with purified STARD4 and liposomes for mechanistic studies.
• Is amenable to CRISPR knockout, point-mutation, and knock-in modeling in human cell lines.
• Links sterol metabolism to growth signalling at ER-lysosome contact sites.
• Represents a distinct molecular function separate from sterol synthesis and sterol sensing.
What Happens During sterol transfer activity?
Sterol extraction from the donor membrane
In simple terms: The transfer protein pulls a cholesterol molecule out of the membrane where it was sitting.
The first step of sterol transfer activity is removal of a sterol from a donor membrane or monolayer lipid particle. The protein must overcome the hydrophobic environment of the membrane and insert a hydrophobic pocket or tunnel to capture the sterol. Structural studies of human STARD4 show a conserved sterol-binding pocket that accommodates cholesterol and related sterols. This extraction step is rate-limiting for many transfer proteins and is regulated by membrane composition and sterol availability.
Protected transport through the aqueous phase
In simple terms: The protein carries the cholesterol through water while hiding it inside a greasy pocket so it does not float away.
After extraction, the sterol is shielded from the aqueous cytoplasm inside a hydrophobic pocket of the transfer protein. This protected transport distinguishes true sterol transfer activity from passive sterol diffusion. STARD4 and related START-domain proteins use a compact alpha-helical fold that buries the sterol during transit. The aqueous phase would otherwise be a barrier because sterols are nearly insoluble in water, so the hydrophobic pocket is essential for function.
Delivery to the acceptor membrane or lipid particle
In simple terms: The protein releases the cholesterol into the target membrane or lipid droplet.
The final step is insertion of the sterol into an acceptor membrane or monolayer lipid particle. This delivery step determines the directionality of sterol flow and can be coupled to sterol sensing or lipid counter-exchange. In cells, delivery to the plasma membrane, ER, or lipid droplets maintains sterol gradients and supports lipid droplet metabolism. Defects in delivery cause sterol accumulation in donor compartments, as seen in Niemann-Pick type C disease.
Coupling to organelle contact sites
In simple terms: Sterol transfer often happens where two organelles touch, so the cholesterol can hop directly from one to the other.
Many sterol transfer proteins act at membrane contact sites between the ER and lysosomes, mitochondria, or the plasma membrane. ER-lysosome contacts enable cholesterol sensing by mTORC1, and disruption of these contacts in Niemann-Pick type C disease drives aberrant growth signalling. Intramitochondrial cholesterol transfer is required for steroidogenesis and depends on contact-site machinery. These contact sites concentrate transfer proteins and coordinate sterol movement with signalling and metabolism.
Integration with sterol biosynthesis and esterification
In simple terms: Moving cholesterol around is tightly linked to making it and storing it.
Sterol transfer activity is integrated with cholesterol biosynthesis and esterification. Defects in CYB5A and CYB5B impact sterol-C4 oxidation in cholesterol biosynthesis and alter dimethyl sterol levels, showing that sterol intermediates influence transfer and storage pathways. Lipid droplet metabolism depends on sterol transfer for neutral lipid storage and mobilization. Together, these pathways maintain cellular sterol homeostasis.
Key Genes Involved in GO:0120015 sterol transfer activity
The following genes and proteins are experimentally linked to sterol transfer activity, non-vesicular sterol movement, or related sterol trafficking pathways.
| Gene | Major Role | Research Relevance |
|---|---|---|
| STARD4 | Cytosolic sterol transfer protein with a hydrophobic sterol-binding pocket | Structural and biochemical studies of sterol transfer mechanism |
| STARD5 | START-domain sterol transfer protein | Sterol transfer and ER stress studies |
| NPC1 | Lysosomal membrane protein required for cholesterol egress | Niemann-Pick type C disease and mTORC1 signalling |
| NPC2 | Lysosomal soluble cholesterol-binding protein | Niemann-Pick type C disease and lysosomal sterol transfer |
| OSBP | Oxysterol-binding protein with sterol transfer and PI4P exchange activity | Membrane contact site and sterol transfer studies |
| ORP family | Oxysterol-binding protein-related proteins that transfer sterols | Non-vesicular sterol transport and lipid homeostasis |
| CYP11A1 | Mitochondrial cholesterol side-chain cleavage enzyme | Intramitochondrial cholesterol transfer for steroidogenesis |
| STAR | Steroidogenic acute regulatory protein | Mitochondrial cholesterol transfer and steroidogenesis |
| CYB5A | Cytochrome b5 involved in sterol-C4 oxidation | Cholesterol biosynthesis and dimethyl sterol regulation |
| CYB5B | Cytochrome b5 involved in sterol-C4 oxidation | Cholesterol biosynthesis and sterol intermediate studies |
| ABCA1 | Cholesterol efflux transporter | Macrophage sterol efflux and atherosclerosis |
| ABCG1 | Cholesterol efflux transporter | Macrophage sterol efflux and atherosclerosis |
| CH25H | 25-Hydroxycholesterol synthesizing enzyme | Macrophage oxysterol production and vascular inflammation |
| SOAT1 | Sterol O-acyltransferase that esterifies cholesterol | Lipid droplet sterol storage |
| PLIN2 | Lipid droplet coat protein | Lipid droplet metabolism and sterol storage |
| mTORC1 | Growth signalling kinase complex | Cholesterol sensing at ER-lysosome contacts |
| LAMP1 | Lysosomal membrane marker | ER-lysosome contact and lysosomal sterol studies |
How Is sterol transfer activity Regulated?
Sterol transfer activity is regulated by membrane contact site architecture, sterol availability, and signalling pathways. ER-lysosome contacts enable cholesterol sensing by mTORC1, and loss of NPC1 function in Niemann-Pick type C disease causes aberrant mTORC1 signalling. Macrophage-derived 25-hydroxycholesterol promotes vascular inflammation and lesion remodeling, linking oxysterol signalling to sterol transfer and atherogenesis. Sterol transfer proteins are also regulated by their lipid environment and by interaction with partner proteins at contact sites. Cholesterol biosynthesis intermediates, such as dimethyl sterols affected by CYB5A and CYB5B defects, can influence sterol transfer and storage pathways. Lipid droplet dynamics further modulate sterol availability for transfer reactions.
sterol transfer activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NPC1 | Niemann-Pick type C disease; lysosomal cholesterol trapping | NPC1 knockout HeLa or patient fibroblasts |
| NPC2 | Niemann-Pick type C disease; lysosomal sterol transfer | NPC2 knockout cell lines |
| CH25H | Atherosclerosis; macrophage oxysterol production | CH25H knockout macrophages |
| CYB5A | Cholesterol biosynthesis defect; sterol-C4 oxidation | CYB5A knockout HepG2 cells |
| STARD4 | Sterol transfer and membrane homeostasis | STARD4 knockout or overexpression cell lines |
Niemann-Pick type C disease
Niemann-Pick type C disease is caused by defects in NPC1 or NPC2, which are required for lysosomal cholesterol egress. Loss of this sterol transfer function traps cholesterol in lysosomes and drives aberrant mTORC1 growth signalling at ER-lysosome contacts. This makes NPC1 and NPC2 central models for studying sterol transfer activity in human disease.
Atherosclerosis and vascular inflammation
Macrophage-derived 25-hydroxycholesterol promotes vascular inflammation, atherogenesis, and lesion remodeling. Sterol transfer and oxysterol production in macrophages contribute to foam cell formation and plaque progression, linking GO:0120015 to cardiovascular disease.
Steroidogenic and metabolic disorders
Intramitochondrial cholesterol transfer is required for steroid hormone synthesis, and defects in this process impair steroidogenesis. Cholesterol biosynthesis defects involving CYB5A and CYB5B alter sterol-C4 oxidation and dimethyl sterol levels, showing how sterol transfer intersects with metabolic disease.
Lipid droplet and metabolic dysfunction
Lipid droplet metabolism depends on sterol transfer for neutral lipid storage and mobilization. Dysregulation of sterol movement into and out of lipid droplets contributes to metabolic dysfunction and is studied in hepatocytes and adipocytes.
From sterol transfer activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of NPC1 cause lysosomal cholesterol accumulation? | NPC1 knockout HeLa or fibroblast cells |
| Does STARD4 point mutation alter sterol binding? | STARD4 point-mutation knock-in cells |
| Can tagged STARD4 track sterol transfer in live cells? | Tagged knock-in STARD4 cell line |
| Does CH25H overexpression increase oxysterol production? | CH25H overexpression macrophages |
| Does CYB5A knockout alter sterol-C4 oxidation? | CYB5A knockout HepG2 cells |
| Does mTORC1 sense cholesterol at ER-lysosome contacts? | NPC1 knockout cells with mTORC1 reporters |
How to Study the sterol transfer activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Liposome sterol transfer assay | Rate of sterol movement between membranes | Purified STARD4 mechanism |
| Fluorescence microscopy | Sterol distribution and contact sites | ER-lysosome cholesterol sensing |
| Lipidomics / mass spectrometry | Cholesterol, oxysterol, and sterol intermediate levels | NPC1 and CYB5A studies |
| CRISPR knockout screen | Genes required for sterol transfer phenotypes | Lysosomal cholesterol egress |
| CRISPR activation screen | Genes that enhance sterol transfer | Lipid droplet and sterol storage |
| Western blot | Protein expression of transfer proteins | STARD4 and NPC1 validation |
| Immunofluorescence | Subcellular localization of transfer proteins | Contact site studies |
| Oxysterol quantification | 25-hydroxycholesterol and related oxysterols | Macrophage inflammation studies |
Liposome-based sterol transfer assays
Reconstituted liposome assays with purified sterol transfer proteins such as STARD4 measure the rate of sterol movement between donor and acceptor membranes. These assays define the molecular function of GO:0120015 in a defined system and allow mutational analysis of the hydrophobic pocket.
Fluorescence and imaging of sterol trafficking
Fluorescent sterol analogs and tagged transfer proteins can be imaged to track sterol movement between organelles in live cells. Imaging at ER-lysosome contacts reveals how cholesterol sensing and mTORC1 signalling are spatially organized.
Lipidomics and sterol profiling
Mass spectrometry-based lipidomics quantifies cholesterol, oxysterols, and sterol intermediates in cells and tissues. This approach detects sterol accumulation or depletion caused by defects in sterol transfer activity.
CRISPR-based genetic screens
CRISPR knockout and activation screens can identify genes required for sterol transfer, lysosomal cholesterol egress, and lipid droplet homeostasis. These screens link candidate genes to sterol transfer phenotypes in human cells.
How CRISPR Can Be Used to Study GO:0120015 sterol transfer activity
Knockout
CRISPR knockout of NPC1, NPC2, or STARD4 creates cell models with defective sterol transfer, enabling studies of lysosomal cholesterol accumulation, mTORC1 signalling, and lipid droplet dynamics. Knockout macrophages for CH25H reduce oxysterol production and vascular inflammation phenotypes.
Point Mutation
Point-mutation knock-in of residues in the STARD4 sterol-binding pocket allows structure-function analysis of sterol transfer activity. Disease-relevant mutations in NPC1 can be modeled to dissect lysosomal sterol egress defects.
Knock-in
Tagged knock-in of STARD4 or NPC1 with fluorescent or affinity tags enables live-cell imaging and proteomic analysis of sterol transfer complexes. Knock-in reporters can also monitor mTORC1 activity at ER-lysosome contacts.
Overexpression
Overexpression of CH25H or STARD4 increases oxysterol production or sterol transfer flux, respectively, allowing gain-of-function studies in macrophages and other cell types. Overexpression models complement knockout studies to establish causality in sterol transfer pathways.
How EDITGENE Supports sterol transfer activity Research
Researchers studying sterol transfer activity-related genes often need to determine whether a candidate gene is causally involved in sterol movement, lysosomal cholesterol egress, or lipid droplet homeostasis. Establishing causality requires precise genetic models that isolate the molecular function of GO:0120015 from secondary metabolic effects. EDITGENE provides CRISPR-engineered cell models and screening services tailored to sterol transfer research.
Contact EDITGENE today to design your custom CRISPR model for sterol transfer activity research.
Frequently Asked Questions About sterol transfer activity
What is sterol transfer activity GO:0120015?
GO:0120015 sterol transfer activity is a molecular function that removes a sterol from a membrane or monolayer lipid particle, transports it through the aqueous phase inside a hydrophobic pocket, and delivers it to an acceptor membrane or lipid particle.
What genes are involved in sterol transfer activity?
Key genes include STARD4, STARD5, NPC1, NPC2, OSBP, ORP family members, CYP11A1, STAR, CYB5A, CYB5B, ABCA1, ABCG1, CH25H, SOAT1, and PLIN2.
How is sterol transfer different from cholesterol synthesis?
Sterol transfer moves existing sterols between membranes, whereas cholesterol synthesis builds sterols from acetyl-CoA precursors; GO:0120015 specifically describes the transfer function.
What diseases are linked to defective sterol transfer?
Niemann-Pick type C disease, atherosclerosis, steroidogenic disorders, and lipid droplet-related metabolic dysfunction are linked to defective sterol transfer.
How do researchers measure sterol transfer activity?
Common methods include liposome-based transfer assays, fluorescence imaging, lipidomics, and CRISPR screens.
What is the role of NPC1 in sterol transfer?
NPC1 is a lysosomal membrane protein required for cholesterol egress; its loss causes lysosomal cholesterol trapping and aberrant mTORC1 signalling in Niemann-Pick type C disease.
Can CRISPR knockout cells model sterol transfer defects?
Yes, CRISPR knockout of NPC1, NPC2, STARD4, or CH25H creates cell models with defective sterol transfer for mechanistic and disease studies.
What is the role of STARD4 in sterol transfer?
STARD4 is a cytosolic sterol transfer protein with a hydrophobic sterol-binding pocket that mediates non-vesicular sterol movement.
How does 25-hydroxycholesterol relate to sterol transfer?
Macrophage-derived 25-hydroxycholesterol promotes vascular inflammation and atherogenesis, linking oxysterol production to sterol transfer pathways.
What model systems are used to study sterol transfer activity?
Models include purified protein liposome assays, knockout and knock-in cell lines, overexpression cells, and CRISPR screens.
Conclusion
GO:0120015 sterol transfer activity defines a protein-mediated molecular function that moves sterols between membranes and lipid particles through a protected hydrophobic pocket. Its importance spans lysosomal cholesterol egress, mTORC1 signalling, macrophage inflammation, steroidogenesis, and lipid droplet metabolism. CRISPR-engineered cell models and biochemical assays provide the tools needed to dissect this activity and its role in human disease.
References
- 1. Canfrán-Duque A et al.. 2023. Macrophage-Derived 25-Hydroxycholesterol Promotes Vascular Inflammation, Atherogenesis, and Lesion Remodeling.. Circulation 147(5):388-408 PMID: 36416142
- 2. Lim CY et al.. 2019. ER-lysosome contacts enable cholesterol sensing by mTORC1 and drive aberrant growth signalling in Niemann-Pick type C.. Nat Cell Biol 21(10):1206-1218 PMID: 31548609
- 3. Scallen TJ et al.. 1985. Sterol carrier and lipid transfer proteins.. Chem Phys Lipids 38(3):239-61 PMID: 3910286
- 4. Tan L et al.. 2019. Structural analysis of human sterol transfer protein STARD4.. Biochem Biophys Res Commun 520(2):466-472 PMID: 31607485
- 5. Fielding CJ et al.. 1997. Intracellular cholesterol transport.. J Lipid Res 38(8):1503-21 PMID: 9300773
- 6. Ma MY et al.. 2024. Defects in CYB5A and CYB5B impact sterol-C4 oxidation in cholesterol biosynthesis and demonstrate regulatory roles of dimethyl sterols.. Cell Rep 43(11):114912 PMID: 39489939
- 7. Stocco DM. 2000. Intramitochondrial cholesterol transfer.. Biochim Biophys Acta 1486(1):184-97 PMID: 10856721
- 8. Khor VK et al.. 2013. Lipid droplet metabolism.. Curr Opin Clin Nutr Metab Care 16(6):632-7 PMID: 24100667
